Advances in Cardiovascular Drug Discovery

Recent breakthroughs in cardiovascular drug discovery are transforming treatment strategies for heart disease. Cutting-edge research focuses on identifying novel molecular targets, including ion channels, receptors, and enzymes involved in heart failure, hypertension, and arrhythmias. Advances in high-throughput screening, molecular modeling, and drug repurposing are accelerating the development of innovative therapies. New classes of drugs, such as RNA-based therapeutics, gene therapies, and targeted biologics, show promising potential for personalized treatment. This session will explore the latest discoveries and discuss how these innovations could lead to more effective, safer, and individualized cardiovascular therapies for patients worldwide.

 

    Related Conference of Advances in Cardiovascular Drug Discovery

    May 05-06, 2025

    19th World Drug Delivery Summit

    Vancouver, Canada
    June 16-17, 2025

    3rd Global Online Summit on Nanoscience and Nanotechnology

    Zurich, Switzerland
    June 23-24, 2025

    38th World Congress on Pharmacology

    Paris, France
    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Aix-en-Provence, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    13th International Conference on Clinical Trials

    Amsterdam, Netherlands
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland

    Advances in Cardiovascular Drug Discovery Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in